Cargando…

Association of Plasma Myeloperoxidase Level with Risk of Coronary Artery Disease in Patients with Type 2 Diabetes

Aims. This study aimed to investigate whether the change of plasma myeloperoxidase (MPO) level would be associated with the incidence of coronary artery disease (CAD) among diabetic patients. Methods. 339 patients with type 2 diabetes mellitus (DM) underwent coronary angiography. Of them, 204 cases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Ping, Xu, Jin, Song, Yongfeng, Jiang, Shiliang, Yuan, Haitao, Zhang, Xu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4588338/ https://www.ncbi.nlm.nih.gov/pubmed/26451069 http://dx.doi.org/10.1155/2015/761939

Ejemplares similares

Level and significance of plasma myeloperoxidase and the neutrophil to lymphocyte ratio in patients with coronary artery disease
por: MAYYAS, FADIA A., et al.
Publicado: (2014)

Myeloperoxidase polymorphism and coronary artery disease risk: A meta-analysis
por: Wang, Yan, et al.
Publicado: (2017)

Association between serum myeloperoxidase levels and coronary artery disease in patients without diabetes, hypertension, obesity, and hyperlipidemia
por: Hasanpour, Zahra, et al.
Publicado: (2016)

Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease
por: Kimak, Elżbieta, et al.
Publicado: (2018)

Salivary and plasma levels of matrix metalloproteinase-9 and myeloperoxidase at rest and after acute physical exercise in patients with coronary artery disease
por: Mahmood, Zeid, et al.
Publicado: (2019)

Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina
por: Baseri, Mehdi, et al.
Publicado: (2014)

Myeloperoxidase gene-463G > A polymorphism and premature coronary artery disease
por: Zhong, Chen, et al.
Publicado: (2009)

The roles of myeloperoxidase in coronary artery disease and its potential implication in plaque rupture
por: Teng, Nathaniel, et al.
Publicado: (2016)

A myeloperoxidase precursor, pro-myeloperoxidase, is present in human plasma and elevated in cardiovascular disease patients
por: Khalilova, Irada S., et al.
Publicado: (2018)

Impact of myeloperoxidase dosage in acute coronary syndrome
por: Esporcatte, R, et al.
Publicado: (2005)

Myeloperoxidase Levels in Pericardial Fluid Is Independently Associated with Postoperative Atrial Fibrillation after Isolated Coronary Artery Bypass Surgery
por: Liu, Yuhua, et al.
Publicado: (2022)

Significance of myeloperoxidase plasma levels as a predictor for cardiac resynchronization therapy response
por: Sultan, A., et al.
Publicado: (2020)

Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification
por: van Eupen, Marcelle GA, et al.
Publicado: (2013)

Polymorphisms in FADS1 and FADS2 alter plasma fatty acids and desaturase levels in type 2 diabetic patients with coronary artery disease
por: Li, Si-Wei, et al.
Publicado: (2016)

Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study
por: Nita, Cristina, et al.
Publicado: (2014)

Correlation Analysis of Plasma Myeloperoxidase Level With Global Registry of Acute Coronary Events Score and Prognosis in Patients With Acute Non-ST-Segment Elevation Myocardial Infarction
por: Zhang, Nan, et al.
Publicado: (2022)

Myeloperoxidase Is Not Useful for Detecting Stress Inducible Myocardial Ischemia but May Be Indicative of the Severity of Coronary Artery Disease
por: Schuhmann, Christoph G., et al.
Publicado: (2014)

Plasma myeloperoxidase-conjugated DNA level predicts outcomes and organ dysfunction in patients with septic shock
por: Maruchi, Yuki, et al.
Publicado: (2018)

Prediction of short-term clinical outcome of percutaneous coronary intervention in patients with acute coronary syndrome through myeloperoxidase levels
por: Pourmoghaddas, Ali, et al.
Publicado: (2014)

Decreased Plasma Myeloperoxidase Associated with Probiotic Therapy in Autistic Children
por: Russo, Anthony J.
Publicado: (2015)

Correlation between plasma renalase level and coronary artery disease
por: He, Benhong, et al.
Publicado: (2014)

Association between myeloperoxidase rs2333227 polymorphism and susceptibility to coronary heart disease
por: Zhang, Yi-Qing, et al.
Publicado: (2020)

Association between Myeloperoxidase Levels and Risk of Insulin Resistance in Egyptian Obese Women
por: Zaki, Moushira, et al.
Publicado: (2018)

Further evaluation of plasma sphingomyelin levels as a risk factor for coronary artery disease
por: Schlitt, Axel, et al.
Publicado: (2006)

Effects of methylprednisolone on exercise-induced increases of plasma levels of polymorphonuclear elastase and myeloperoxidase in man. Preliminary results
por: Camus, G., et al.
Publicado: (1993)

Common variable immunodeficiency patients display elevated plasma levels of granulocyte activation markers elastase and myeloperoxidase
por: Litzman, Jiří, et al.
Publicado: (2019)

Positive correlation between plasma PCSK9 and tissue factors levels in patients with angiographically diagnosed coronary artery disease and diabetes mellitus
por: Wang, Mei, et al.
Publicado: (2016)

Plasma myeloperoxidase: association with atrial fibrillation progression and recurrence after catheter ablation
por: Liu, Jingmeng, et al.
Publicado: (2023)

PRISMA-combined Myeloperoxidase -463G/A gene polymorphism and coronary artery disease: A meta-analysis of 4744 subjects
por: Li, Yan-Yan, et al.
Publicado: (2017)

Levels of IL-8 and myeloperoxidase in the lungs of pneumonia patients
por: Abul, H., et al.
Publicado: (2001)

Comparing mortality and myocardial infarction between coronary artery bypass grafting and drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis
por: Qi, Xiaolong, et al.
Publicado: (2014)

Fasting plasma glucose levels and coronary artery calcification in subjects with impaired fasting glucose
por: Eun, Young-Mi, et al.
Publicado: (2016)

A rapid bioluminescence assay for measuring myeloperoxidase activity in human plasma
por: Goiffon, Reece J., et al.
Publicado: (2015)

SNP rs2243828 in MPO associated with myeloperoxidase level and atrial fibrillation risk in Chinese Han population
por: Wang, Pengyun, et al.
Publicado: (2020)

Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease
por: Chaudhary, Rajesh, et al.
Publicado: (2012)

Higher Plasma Thrombospondin-1 Levels in Patients With Coronary Artery Disease and Diabetes Mellitus
por: Choi, Kyu-Young, et al.
Publicado: (2012)

Association of myeloperoxidase, homocysteine and high-sensitivity C-reactive protein with the severity of coronary artery disease and their diagnostic and prognostic value
por: Cheng, Minju, et al.
Publicado: (2020)

Two-year prognostic value of mean platelet volume in patients with diabetes and stable coronary artery disease undergoing elective percutaneous coronary intervention
por: Jiang, Ping, et al.
Publicado: (2019)

ADAMTS-5 Decreases in Coronary Arteries and Plasma from Patients with Coronary Artery Disease
por: Wang, Zhen, et al.
Publicado: (2019)

Plasminogen and fibrinogen plasma levels in coronary artery disease
por: Lima, Luciana Moreira, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8956at9ukndmp5rdb8cac4p6kb